Design of Active-Site-Directed Irreversible Enzyme Inhibitors. Alfred. Burger. J. Med. Chem. , 1967, 10 (6), pp 1196â1196. DOI: 10.1021/jm00318a065. Publication Date: November 1967. ACS Legacy Archive. Note: In lieu of an abstract, this is the arti
CXXIII. Candidate irreversible inhibitors of guanine deaminase and xanthine oxidase derived from 9-phenylguanine substituted with a terminal sulfonyl fluoride.
Candidate Irreversible Inhibitors of. Guanine Deaminase and Xanthine Oxidase Derived from 9-Pheny lguanine. Substituted with a Terminal Sulfonyl Fluoride.
Citation data is made available by participants in Crossref's Cited-by Linking service. For a more .... S.M.S. Chauhan , H. Junjappa. Tetrahedron 1976 32 (15), ...
Aug 6, 1970 - The pH of this clear soln was raised from 2 to 5 by grad- ually adding about 50 g of ... inhibitors of the C'la component of complement. The good ...
TABLE I irzeta isomer (12). These studies, on 11 and 12, although completed after those on the ... of the cx group of 17 aIld 18 J+-ith a pt, catalyst pro- ceeded in ...
(p-Amidinophenyl)methanesulfonyl fluoride, an irreversible inhibitor of serine proteases. Richard Laura , David J. Robison , and David H. Bing. Biochemistry ...
Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a ...
Jun 6, 1970 - Twenty-six active-site-directed irreversible inhibitors of dihydrofolic reductase of the ... in the structure of the enzyme as previously supposed8,6.
Inhibitors of Thymidine Phosphorylase. VIII. Further Studies on Hydrophobic Bonding with 6-Substituted Uracils. B. R. Baker, Waclaw. Rzeszotarski. J. Med.
